ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The company has five subsidiaries: ProPhase Diagnostics, TK Supplements®, Pharmaloz, ProPhase Global Healthcare and ProPhase Precision Medicine.
Our leading subsidiary, ProPhase Diagnostics, offers an array of clinical diagnostic insights and testing services at its CLIA-certified labs. There, we conduct polymerase chain reaction (PCR) testing, antigen testing and antibody testing for SARS-CoV-2 (COVID-19). Through both saliva and nasal swab sampling, our methodology can identify the possibility of mutations and provide results in less than 24 hours.
The parent company, ProPhase Labs, researches, develops, manufactures, distributes, markets, and sells OTC consumer healthcare products and dietary supplements, including under the TK Supplements® brand. The company actively pursues strategic investments and acquisition opportunities for other companies, technologies, and products.